NCT03534713 - Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread | Biotech Hunter

Enrollment

310

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

Cervical Cancer TNM Staging Regional Lymph Nodes (N)

Interventions

DRUG

Carboplatin

carboplatin aera Under curve 5 on day 1, every 21 days during 3 cycles

DRUG

Paclitaxel

paclitaxel 175 mg/m² on day 1, every 21 days during 3 cycles

DRUG

Cisplatin

Cisplatin 40mg/m² given once a week during 5 weeks

RADIATION

Radiotherapy

45 gray to the pelvis and para aortic area over 5 weeks + intracavitary brachytherapy alone or prior to surgery, depending on response to treatment according to the current guidelines

Trial Locations (11)

13009

RECRUITING

Institut Paoli Calmettes, Marseille

31059

RECRUITING

Clinique Pasteur, Toulouse

33000

RECRUITING

CHU de Bordeaux, Bordeaux

37044

RECRUITING

CHU de Tours, Tours

44805

RECRUITING

Institut de Cancérologie de l'Ouest - Nantes, Saint-Herblain

63011

RECRUITING

Centre Jean Perrin, Clermont-Ferrand

69495

RECRUITING

CH Lyon Sud, Pierre-Bénite

86000

RECRUITING

CHU de Poitiers, Poitiers

94000

RECRUITING

CHI Créteil, Créteil

97448

RECRUITING

CHU La Réunion, Saint-Pierre

Unknown

RECRUITING

University Hospital Toulouse, Toulouse

All Listed Sponsors

collaborator

Institut Claudius Regaud

OTHER

lead

University Hospital, Toulouse

OTHER